Probably don't need to at this stage. Sales are probably higher then expected so why advertise now when it would make more sense to advertise after more roll outs have occurred.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling
